Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients.

Huiwen GuoJiangqiang XiaoYi WangMing ZhangYuzheng Zhuge Feng Zhang

Published in: BioMed research international (2021)

Increase ≥ 1.75 mmHg in FHVP responding to beta-blockers in cirrhotic patients with GOV indicates high risk of variceal bleeding. Besides HVPG response, change of FHVP should also be valued in hemodynamic evaluation to beta-blockers. This trial is registered with Chinese Clinical Trial Registry ChiCTR-IPR-17012836.

Keyphrases

clinical trial
angiotensin converting enzyme
end stage renal disease
atrial fibrillation
study protocol
ejection fraction
chronic kidney disease
phase ii
newly diagnosed
phase iii
prognostic factors
randomized controlled trial
angiotensin ii
patient reported outcomes
patient reported
clinical evaluation